CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease

Clin Lymphoma Myeloma Leuk. 2023 May 12:S2152-2650(23)00157-X. doi: 10.1016/j.clml.2023.05.007. Online ahead of print.NO ABSTRACTPMID:37263876 | DOI:10.1016/j.clml.2023.05.007
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research